Colgate-Palmolive Company (NYSE:CL) is one of the most profitable consumer stocks to buy now. UBS lowered its price target on ...

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.

Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...

Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last six months. At the same time, the S&P 500 has returned 5%. Is now a good ...

Santo Domingo.- Health authorities in the Dominican Republic have issued a warning about potential adverse reactions linked ...

Colgate-Palmolive is set to announce its second-quarter results early next month, with analysts expecting a modest ...

Colgate-Palmolive boasts strong brands, growth in Pet Nutrition, and 62 years of dividend increases but faces valuation concerns. See more on CL stock here.

Next week will see more than 150 companies from diverse sectors, including banking, pharmaceuticals, fintech, cement, and IT, ...

Colgate-Palmolive (NYSE: CL) shares rose premarket after Q1 FY25 earnings beat expectations. Revenue hit $4.91B, topping estimates, with 1.4% organic sales growth and $0.91 EPS exceeding forecasts.

Colgate-Palmolive (NYSE:CL) is set to give its latest quarterly earnings report on Friday, 2025-04-25. Here's what investors need to know before the announcement. Analysts estimate that Colgate ...